Esmya 5mg Tablets (Ulipristal acetate) - Important Safety Information from Gedeon Richter UK Ltd as approved by the HPRA

Notice type: 3rd Party Publications

Date: 24/03/2020




Problem Or Issue:

Important Safety Information from Gedeon Richter UK Ltd regarding Esmya 5mg Tablets (Ulipristal acetate) for uterine fibroids not to be used during ongoing review of liver injury risk


Important Safety Information - Esmya 5mg Tablets (Ulipristal acetate)




« Back